Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300408 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Korina Yun-Fan Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Harvard School of Dental Medicine, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: COVID-19, Sputum, Saliva, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCR NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
SARS-CoV-2, a severe respiratory disease primarily targeting the lungs, was the leading cause of death worldwide during the pandemic. Understanding the interplay between the oral microbiome and inflammatory cytokines during acute infection is crucial for elucidating host immune responses. This study aimed to explore the relationship between the oral microbiome and cytokines in COVID-19 patients, particularly those with and without sputum production. Saliva and blood samples from 50 COVID-19 patients were subjected to 16S ribosomal RNA gene sequencing for oral microbiome analysis, and 65 saliva and serum cytokines were assessed using Luminex multiplex analysis. The Mann-Whitney test was used to compare cytokine levels between individuals with and without sputum production. Logistic regression machine learning models were employed to evaluate the predictive capability of oral microbiome, salivary, and blood biomarkers for sputum production. Significant differences were observed in the membership (Jaccard dissimilarity: p = 0.016) and abundance (PhILR dissimilarity: p = 0.048; metagenomeSeq) of salivary microbial communities between patients with and without sputum production. Seven bacterial genera, including Prevotella , Streptococcus , Actinomyces , Atopobium , Filifactor , Leptotrichia , and Selenomonas , were more prevalent in patients with sputum production (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard School of Dental Medicine, Boston, Massachusetts, United States of America.
- Tufts University School of Dental Medicine, Boston, Massachusetts, United States of America.
- Dasman Diabetes Institute, Dasman, Kuwait.
- Kuwait Ministry of Health, Sulaibikhat, Kuwait.
- Department of Preventive Dentistry, Division of Pediatric Dentistry, Umm Al-Qura University, Mekkah, Saudi Arabia.
- Department of Genomic Medicine and Infectious Diseases, J. Craig Venter Institute, La Jolla, California, United States of America.
ORCID-Profile: Korina Yun-Fan Lu, Hend Alqaderi, Saadoun Bin Hasan, Sriraman Devarajan, Marcelo Freire, Khaled Altabtbaei
Förderung
- NIAID NIH HHS
- NIDCR NIH HHS
- NHGRI NIH HHS
- J. Craig Venter Institute
- Dasman Diabetes Institute
- L'Oreal USA
Zitieren
APA
Lu, K. Y., Alqaderi, H., Bin Hasan, S., Alhazmi, H., Alghounaim, M., Devarajan, S., Freire, M., & Altabtbaei, K. (2024). Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0300408
Vancouver
Lu KY, Alqaderi H, Bin Hasan S, Alhazmi H, Alghounaim M, Devarajan S, et al. Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis. PLOS ONE. 2024. doi:10.1371/journal.pone.0300408
BibTeX
@article{Lu2024,
author = {Lu, Korina Yun-Fan and Alqaderi, Hend and Bin Hasan, Saadoun and Alhazmi, Hesham and Alghounaim, Mohammad and Devarajan, Sriraman and Freire, Marcelo and Altabtbaei, Khaled},
title = {Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300408}
}
EUVIMED